| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Olson Lisa is a See Remarks at Dianthus Therapeutics, Inc. /DE/. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 5,736 | $6.73 | $38,603.28 | -28.7% | -27.5% | -75.5% |